 |
 |
|
New PharmaVentures Intelligence reportDownload your free 2-page article with highlights from our new report on pricing and reimbursement"Deal Making in the New Healthcare Landscape - Leveraging your Deal through Pricing and Reimbursement Considerations" is a new and unique report which not only provides you with a detailed understanding of the new Pricing and Reimbursement reality, and its impact on drug development plans, but, more importantly, demonstrates clearly and authoritatively how this can be effectively integrated into the deal making process in order to gain a significant competitive advantage. To download your complimentary copy of PharmaVentures' 2-page overview article examining the highlights of "Pricing and Reimbursement" considerations in relation to deal making click here. Alternatively find out more about this report, or order your copy today. |
||
 |
 |
 |
Market News and TrendsDuring January 2006, PharmaDeals Agreements recorded 20 deals that related to drug delivery. The majority of the deals involved transactions between start-up/emerging companies and focused upon licensing, rights and co-development agreements. Three deals involved global companies, including MedPharm's licensing evaluation agreement with an undisclosed international pharmaceutical company for its MedSpray™ technology. Other deals included Inovio Biomedical's agreement with Swedish-based Tripep to deliver a therapeutic vaccine for hepatitis C virus and Supernus Pharmaceuticals' acquisition of Shire Laboratories' product formulation and development assets. Read more... |
||
|
|
||
Featured ArticleLiposome Solutions for Poorly Soluble DrugsThousands of new compounds can be synthesised each year thanks to developments in combinatorial chemistry and high iv throughput screening. This has led to dramatic acceleration in drug discovery output. However, this has not come without fresh problems, with many new lead compounds now reflecting the properties of the screening library to a greater extent. In this article, Azal Ur-Rahman Mohammed and Yvonne Perrie, of the Medicines Research Unit, Aston University, Birmingham, discuss the application of liposomes as drug delivery systems and their potential as novel solutions for poor solubility. Read more... |
 |
||
|
|
||
 |
Company ProfilesBespak, AP Pharma, Pharmaceutical Profiles, Direct-Haler |
||
|
|
||
Drug Delivery OpportunitiesView all our Drug Delivery Opportunities or alternatively request a password to submit your opportunity online.Featured Opportunity Novel Biomedical Polymer Technology Administrative Route - Ophthalmic, Transdermal, Subcutaneous, Topical Indication - Improve the acceptance of implants and medical devices; particularly designed for optical lenses and drug delivery Licence code LO-0106-03 |
 |
||
|
|
||
 |
Ensure you receive your copy of the Drug Delivery Report Spring / Summer 2006For deal makers actively assessing drug delivery technology receiving your complimentary copy is a must. The DDR blends high-quality articles covering the latest drug developments in conjunction with concise profiles of companies active in specific technology areas.Apply to receive the next edition of the DDR Find out more about promoting your company |
||
Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence - we work with clients to drive greater value from their deals.
If you do not wish to receive DDR E-News in future, please e-mail ddr@pharmamail.biz with the words UNSUBSCRIBE as the subject.
If you do not wish to receive other e-mail communications from PharmaVentures or selected third parties, please e-mail ddr@pharmamail.biz with REMOVE as the subject.
For more details contact
Kate Atherton, Publishing Editor, PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. Tel: +44 (0) 1865 784 177 Fax: +44 (0) 1865 784 178 E-mail ddr@pharmamail.biz